Sirtuins,
NAD(+)-dependent deacetylases, could target both
histones and nonhistone
proteins in mammalian cells.
Sirt1 is the major
sirtuin and has been shown to involve various cellular processes, including antiapoptosis, cellular senescence.
Sirt1 was reported to be overexpressed in many
cancers, including
lung cancer.
Sirtinol, a specific inhibitor of
Sirt1, has been shown to induce apoptosis of
cancer cells by elevating endogenous level of
reactive oxygen species. In the study, we investigated the effect of
sirtinol on the proliferation and apoptosis of
nonsmall cell lung cancer (NSCLC) H1299 cells. The results of proliferation assay and colony formation assay showed the antigrowth effect of
sirtinol. The
annexin-V staining further confirmed the apoptosis induction by
sirtinol treatment. Interestingly, the levels of phosphorylated Akt and β-
catenin were significantly downregulated with treating the apoptotic inducing doses. On the contrary,
sirtinol treatment causes the significantly increased level of FoxO3a, a proapoptotic
transcription factor targeted by
Sirt1. These above results suggested that
sirtinol may inhibit cell proliferation of H1299 cells by regulating the axis of Akt-β-catenin-FoxO3a. Overall, this study demonstrates that
sirtinol attenuates the proliferation and induces apoptosis of NSCLC cells, indicating the potential treatment against NSCLC cells by inhibiting
Sirt1 in future applications.